glp-1 drug market size Agonists Weight Loss Drugs Report, 2025-2030 GLP-1 Market Size, Scope, Forecast

A.MentzR

As patient preferences shift toward effective therapies that offer more than just glucose control, GLP-1 drugs will likely remain central to diabetes care, weight management, and overall metabolic health for years to come

As the scientific community continues to unravel the mysteries of GLP-1, it may very well be the key to unlocking healthier, happier lives for many individuals.

AGA clinical practice guideline on pharmacological interventions for adults with obesity

With retatrutide and other multi-agonists on the horizon, we may soon see drugs that approach the effectiveness of bariatric surgery without the invasiveness